ANI Pharmaceuticals to Showcase Research on Membranous Nephropathy
ANI Pharmaceuticals to Present Research at ASN Kidney Week 2024 ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is set to unveil exciting new pre-clinical data regarding its membranous nephropathy (MN) research. The presentations will take place during two poster sessions at the esteemed American Society of Nephrology (ASN) Kidney Week 2024. The Significance of the ASN Kidney...
Continue Reading.jpg)